GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting
base metals investing Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
base metals investing Cell-Based Therapies Poised to Disrupt Multi-Billion-Dollar Anti-Aging and Neurodegenerative Markets
base metals investing Lineage Cell Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
base metals investing Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
base metals investing OpRegen® 3 Year Results in Patients With GA Presented at Foundation Fighting Blindness Retinal Innovation Summit 2026
gaming investing CORRECTIVE PRESS RELEASE* Apple iSports Group, Inc. Appoints Ian Wilding as Fractional Chief Innovation Advisor to Support Strategic Growth and Nasdaq Readiness
base metals investing Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
